Patents by Inventor Dino De Cicco

Dino De Cicco has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140046360
    Abstract: An implantable device for containing emboli within an atrial appendage may include an expandable frame having a plurality of supports projecting distally from a proximal hub, a mesh barrier provided on proximal sections of the supports, and a plurality of tissue anchors provided on the supports for engaging tissue when the device is positioned in an atrial appendage.
    Type: Application
    Filed: September 3, 2013
    Publication date: February 13, 2014
    Inventors: Erik J. van der Burg, Dino De Cicco, Andrew G.C. Frazier, Alex K. Khairkahan, Marc S. Kriedler, Michael D. Lesh, Chad C. Roue
  • Publication number: 20130331884
    Abstract: Disclosed is an occlusion device for use in a body lumen such as the left atrial appendage. The occlusion device includes a pumpable injectable material and a retention member having a tissue penetrating shaft which extends from a proximal end of the device to a distal end of the device.
    Type: Application
    Filed: August 14, 2013
    Publication date: December 12, 2013
    Inventors: Erik J. Van der Burg, Dino De Cicco, Andrew G.C. Frazier, Alex K. Khairkahan, Marc S. Kriedler, Michael D. Lesh, Chad C. Roue
  • Patent number: 8535343
    Abstract: Disclosed is an occlusion device for use in a body lumen such as the left atrial appendage. The occlusion device includes a pumpable injectable material and a retention member having a tissue penetrating shaft which extends from a proximal end of the device to a distal end of the device.
    Type: Grant
    Filed: May 17, 2011
    Date of Patent: September 17, 2013
    Assignee: Atritech, Inc.
    Inventors: Erik J. van der Burg, Dino De Cicco, Andrew G. C. Frazier, Alex K. Khairkahan, Marc S. Kriedler, Michael D. Lesh, Chad C. Roue
  • Patent number: 8535290
    Abstract: Clot disruption and dissolution are achieved using a catheter having the ability to infuse a thrombolytic agent, aspirate clot and fluid, and allow passage of a guidewire. Optionally, the catheter may also include a mechanical agitator for further disrupt clot in the presence of the thrombolytic agent. A flow resistor in the catheter provides for infusion and/or aspiration to be concentrated primarily at a clot treatment area in a blood vessel while also providing optional infusion and/or aspiration distal to the treatment area. In some embodiments, infusion, aspiration and guidewire passage occur through a common lumen. The thrombolytic agent, such as tPA, streptokinase, or urokinase, is directly released into the clot at the point where the agitator is engaging the clot. In this way, the thrombolytic activity of the agent is enhanced and the dissolution of the clot is improved.
    Type: Grant
    Filed: July 13, 2012
    Date of Patent: September 17, 2013
    Assignee: Covidien LP
    Inventors: Michael A. Evans, Denise Demarais, Dino De Cicco, Kelvin Ning, Alexander Khairkhahan, Tyler Jon Strang
  • Patent number: 8523897
    Abstract: An implantable device for containing emboli within an atrial appendage may include an expandable frame having a plurality of supports projecting distally from a proximal hub, a mesh barrier provided on proximal sections of the supports, and a plurality of tissue anchors provided on the supports for engaging tissue when the device is positioned in an atrial appendage.
    Type: Grant
    Filed: September 27, 2006
    Date of Patent: September 3, 2013
    Assignee: Atritech, Inc.
    Inventors: Erik J. van der Burg, Dino De Cicco, Andrew G. C. Frazier, Alex K. Khairkahan, Marc S. Kriedler, Michael D. Lesh, Chad C. Roue
  • Publication number: 20120283699
    Abstract: Clot disruption and dissolution are achieved using a catheter having the ability to infuse a thrombolytic agent, aspirate clot and fluid, and allow passage of a guidewire. Optionally, the catheter may also include a mechanical agitator for further disrupt clot in the presence of the thrombolytic agent. A flow resistor in the catheter provides for infusion and/or aspiration to be concentrated primarily at a clot treatment area in a blood vessel while also providing optional infusion and/or aspiration distal to the treatment area. In some embodiments, infusion, aspiration and guidewire passage occur through a common lumen. The thrombolytic agent, such as tPA, streptokinase, or urokinase, is directly released into the clot at the point where the agitator is engaging the clot. In this way, the thrombolytic activity of the agent is enhanced and the dissolution of the clot is improved.
    Type: Application
    Filed: July 13, 2012
    Publication date: November 8, 2012
    Applicant: TYCO HEALTHCARE GROUP LP
    Inventors: Michael A. Evans, Denise Demarais, Dino De Cicco, Kelvin Ning, Alexander Khairkhahan, Tyler Jon Strang
  • Patent number: 8241241
    Abstract: Clot disruption and dissolution are achieved using a catheter having the ability to infuse a thrombolytic agent, aspirate clot and fluid, and allow passage of a guidewire. Optionally, the catheter may also include a mechanical agitator for further disrupt clot in the presence of the thrombolytic agent. A flow resistor in the catheter provides for infusion and/or aspiration to be concentrated primarily at a clot treatment area in a blood vessel while also providing optional infusion and/or aspiration distal to the treatment area. In some embodiments, infusion, aspiration and guidewire passage occur through a common lumen. The thrombolytic agent, such as tPA, streptokinase, or urokinase, is directly released into the clot at the point where the agitator is engaging the clot. In this way, the thrombolytic activity of the agent is enhanced and the dissolution of the clot is improved.
    Type: Grant
    Filed: June 15, 2010
    Date of Patent: August 14, 2012
    Assignee: Tyco Healthcare Group LP
    Inventors: Michael A. Evans, Denise Demarias, Dino De Cicco, Kelvin Ning, Alexander Khairkhahan, Tyler Jon Strang
  • Patent number: 8080032
    Abstract: A device and method for obliterating or occluding a body cavity or passageway, in particular, the left atrial appendage of a patient's heart. The procedure can be carried out intraoperatively, but is preferably carried out percutaneously by use of a delivery catheter to position an occluding device adjacent a patient's left atrial appendage. The occluding device may prevent the passage of embolic or other material to or from the left atrial appendage by volumetrically filling the appendage, closing the opening of the appendage with an occluding member, or pulling the tissue around the opening of the appendage together and fixing it in a closed state.
    Type: Grant
    Filed: September 30, 2003
    Date of Patent: December 20, 2011
    Assignee: Atritech, Inc.
    Inventors: Erik J. van der Burg, Dino De Cicco, Andrew G. C. Frazier, Alexander K. Khairkhahan, Marc S. Kreidler, Michael D. Lesh, Chad C. Roue
  • Publication number: 20110218566
    Abstract: Disclosed is an occlusion device for use in a body lumen such as the left atrial appendage. The occlusion device includes an occlusion member and may also include a stabilizing member. The stabilizing member inhibits compression of the left atrial appendage, facilitating tissue in-growth onto the occlusion member. Methods are also disclosed.
    Type: Application
    Filed: May 17, 2011
    Publication date: September 8, 2011
    Applicant: ATRITECH, INC.
    Inventors: Erik J. van der Burg, Dino De Cicco, Andrew G.C. Frazier, Alex K. Khairkahan, Marc S. Kriedler, Michael D. Lesh, Chad C. Roue
  • Publication number: 20110046542
    Abstract: Clot disruption and dissolution are achieved using a catheter having the ability to infuse a thrombolytic agent, aspirate clot and fluid, and allow passage of a guidewire. Optionally, the catheter may also include a mechanical agitator for further disrupt clot in the presence of the thrombolytic agent. A flow resistor in the catheter provides for infusion and/or aspiration to be concentrated primarily at a clot treatment area in a blood vessel while also providing optional infusion and/or aspiration distal to the treatment area. In some embodiments, infusion, aspiration and guidewire passage occur through a common lumen. The thrombolytic agent, such as tPA, streptokinase, or urokinase, is directly released into the clot at the point where the agitator is engaging the clot. In this way, the thrombolytic activity of the agent is enhanced and the dissolution of the clot is improved.
    Type: Application
    Filed: June 15, 2010
    Publication date: February 24, 2011
    Applicant: Bacchus Vascular Inc.
    Inventors: Michael A. Evans, Denise Demarias, Dino De Cicco, Kelvin Ning, Alexander Khairkhahan, Tyler Jon Strang
  • Patent number: 7763010
    Abstract: Clot disruption and dissolution are achieved using a catheter having the ability to infuse a thrombolytic agent, aspirate clot and fluid, and allow passage of a guidewire. Optionally, the catheter may also include a mechanical agitator for further disrupt clot in the presence of the thrombolytic agent. A flow resistor in the catheter provides for infusion and/or aspiration to be concentrated primarily at a clot treatment area in a blood vessel while also providing optional infusion and/or aspiration distal to the treatment area. In some embodiments, infusion, aspiration and guidewire passage occur through a common lumen. The thrombolytic agent, such as tPA, streptokinase, or urokinase, is directly released into the clot at the point where the agitator is engaging the clot. In this way, the thrombolytic activity of the agent is enhanced and the dissolution of the clot is improved.
    Type: Grant
    Filed: May 8, 2002
    Date of Patent: July 27, 2010
    Assignee: Bacchus Vascular inc.
    Inventors: Michael A. Evans, Denise Demarais, Dino De Cicco, Kelvin Ning, Alexander Khairkhahan, Tyler Jon Strang
  • Publication number: 20070083227
    Abstract: Disclosed is an occlusion device for use in a body lumen such as the left atrial appendage. The occlusion device includes an occlusion member and may also include a stabilizing member. The stabilizing member inhibits compression of the left atrial appendage, facilitating tissue in-growth onto the occlusion member. Methods are also disclosed.
    Type: Application
    Filed: September 27, 2006
    Publication date: April 12, 2007
    Inventors: Erik van der Burg, Dino De Cicco, Andrew Frazier, Alex Khairkahan, Marc Kriedler, Michael Lesh, Chad Roue
  • Patent number: 7128073
    Abstract: Disclosed is an occlusion device for use in a body lumen such as the left atrial appendage. The occlusion device includes an occlusion member and may also include a stabilizing member. The stabilizing member inhibits compression of the left atrial appendage, facilitating tissue in-growth onto the occlusion member. Methods are also disclosed.
    Type: Grant
    Filed: November 8, 1999
    Date of Patent: October 31, 2006
    Assignee: ev3 Endovascular, Inc.
    Inventors: Erik J. van der Burg, Dino De Cicco, Andrew G. C. Frazier, Alex K. Khairkahan, Marc S. Kriedler, Michael D. Lesh, Chad C. Roue
  • Patent number: 6994092
    Abstract: Disclosed is an occlusion device for use in a body lumen such as the left atrial appendage. The occlusion device includes an occlusion member and a plurality of tissue retention structures. The tissue retention structures inhibits movement of the device from the left atrial appendage. Methods are also disclosed.
    Type: Grant
    Filed: August 15, 2003
    Date of Patent: February 7, 2006
    Assignee: ev3 Sunnyvale, Inc.
    Inventors: Erik J. van der Burg, Dino De Cicco, Andrew G. C. Frazier, Alexander K. Khairkhahan, Marc S. Kreidler, Michael D. Lesh, Chad C. Roue
  • Patent number: 6929633
    Abstract: Clot disruption and dissolution are achieved using a catheter having the ability to infuse a thrombolytic agent, agitate the clot and agent, and aspirate broken-up clot from the blood vessel. A flow resistor in the catheter provides for infusion and/or aspiration to be concentrated primarily at a clot treatment area in a blood vessel while also providing optional infusion and/or aspiration distal to the treatment area. In some embodiments, infusion, aspiration and guidewire passage occur through a common lumen. The thrombolytic agent, such as tPA, streptokinase, or urokinase, is directly released into the clot at the point where the agitator is engaging the clot. In this way, the thrombolytic activity of the agent is enhanced and the dissolution of the clot is improved.
    Type: Grant
    Filed: October 21, 2002
    Date of Patent: August 16, 2005
    Assignee: Bacchus Vascular, Inc.
    Inventors: Michael A. Evans, Denise Demarais, Dino De Cicco, Kelvin Ning, Alexander Khairkhahan, Tyler Jon Strang, Jody Maria Cimbalo, Stephen Leeflang
  • Publication number: 20050004652
    Abstract: Disclosed is an occlusion device for use in a body lumen such as the left atrial appendage. The occlusion device includes an occlusion member and may also include a stabilizing member. The stabilizing member inhibits compression of the left atrial appendage, facilitating tissue in-growth onto the occlusion member. Methods are also disclosed.
    Type: Application
    Filed: April 22, 2004
    Publication date: January 6, 2005
    Inventors: Eric van der Burg, Dino De Cicco, Andrew Frazier, Alex Khairkahan, Marc Kriedler, Michael Lesh, Chad Roue
  • Publication number: 20040230222
    Abstract: Disclosed is an occlusion device for use in a body lumen such as the left atrial appendage. The occlusion device includes an occlusion member and may also include a stabilizing member. The stabilizing member inhibits compression of the left atrial appendage, facilitating tissue in-growth onto the occlusion member. Methods are also disclosed.
    Type: Application
    Filed: January 30, 2004
    Publication date: November 18, 2004
    Inventors: Erik J. van der Burg, Dino De Cicco, Andrew G.C. Frazier, Alexander K. Khairkhahan, Marc S. Kreidler, Michael D. Lesh, Chad C. Roue
  • Publication number: 20040220610
    Abstract: A biocompatible laminate fabric includes a porous first membrane layer, a porous second membrane layer, and an open mesh bonding layer between the first and second membrane layers. The bonding layer holds the first and second membrane layers together by extending into one or more pores of each membrane layer.
    Type: Application
    Filed: March 17, 2004
    Publication date: November 4, 2004
    Inventors: Marc S. Kreidler, Dino De Cicco, Eric J. van der Burg, Richard S. Kusleika
  • Publication number: 20040098031
    Abstract: A device and method for obliterating or occluding a body cavity or passageway, in particular, the left atrial appendage of a patient's heart. The procedure can be carried out intraoperatively, but is preferably carried out percutaneously by use of a delivery catheter to position an occluding device adjacent a patient's left atrial appendage. The occluding device may prevent the passage of embolic or other material to or from the left atrial appendage by volumetrically filling the appendage, closing the opening of the appendage with an occluding member, or pulling the tissue around the opening of the appendage together and fixing it in a closed state.
    Type: Application
    Filed: September 30, 2003
    Publication date: May 20, 2004
    Inventors: Erik J. van der Burg, Dino De Cicco, Andrew G. C. Frazier, Alexander K. Khairkhahan, Marc S. Kreidler, Michael D. Lesh, Chad C. Roue
  • Publication number: 20040034366
    Abstract: Disclosed is an occlusion device for use in a body lumen such as the left atrial appendage. The occlusion device includes an occlusion member and a plurality of tissue retention structures. The tissue retention structures inhibits movement of the device from the left atrial appendage. Methods are also disclosed.
    Type: Application
    Filed: August 15, 2003
    Publication date: February 19, 2004
    Applicant: EV3 SUNNYVALE, INC., a California corporation
    Inventors: Erik J. van der Burg, Dino De Cicco, Andrew G. C. Frazier, Alexander K. Khairkhahan, Marc S. Kreidler, Michael D. Lesh, Chad C. Roue